Surgery centers and buybacks drive Tenet higher
- Tenet is shifting toward outpatient surgery, where care can be cheaper for patients and more profitable for the company.
- Management raised 2026 adjusted EBITDA guidance by $295 million to a midpoint of $4.93 billion after a strong second quarter.
- The board authorized a massive $2 billion increase to the share repurchase program in July 2026.
- Exchange revenues dropped 17 percent in the second quarter, but cost cuts and AI initiatives helped protect margins.
- The main long-term risk is OBBBA, a 2025 law that Tenet expects will materially affect Medicaid funding and enrollment starting in 2027.
Execution is winning, law risk waits
Tenet is doing what investors wanted. The company is growing the higher-margin USPI surgery-center business, keeping hospitals steady, and using cash for massive buybacks. Second quarter 2026 results supported that story strongly. Management raised full-year 2026 adjusted EBITDA guidance by $295 million at the midpoint and authorized a new $2 billion share repurchase program.
The company is proving it can handle pressure. Exchange revenues fell a significant 17 percent in the second quarter of 2026, but Tenet used flexible expense management and AI initiatives to maintain strong margins. The USPI business continues to be the primary growth engine, driving high-acuity procedures like joint replacements.
Capital returns remain a core part of the thesis. The new $2 billion buyback authorization adds to an already active repurchase strategy. Tenet also expects to deploy more than $300 million into USPI acquisitions for the full year 2026. The Conifer transaction adds another funding source, with $1.9 billion due to Tenet over three years.
The bear case has not gone away, even if near-term execution has muted it. Tenet has not yet given a clear dollar estimate for the 2027 impact of OBBBA on Medicaid coverage, reimbursement, patient volumes, or unpaid care. The stock looks operationally strong, but it still carries a policy risk that is hard to price.
Hospitals fund the outpatient pivot
Tenet makes money by providing care and getting paid by commercial insurers, Medicare, Medicaid, and patients. Its two main pieces are Hospital Operations and Services, plus Ambulatory Care through USPI.
The hospital business is large and important, but it grows more slowly and faces more pressure from labor costs, payer contracts, regulation, and unpaid care. The segment successfully flexed its cost base in the second quarter of 2026 to offset a 17 percent drop in exchange revenues, building an appropriate baseline for future growth.
USPI is the growth engine. It runs ambulatory surgery centers and surgical hospitals, where patients can get procedures without a full hospital stay. The portfolio is intentionally shifting toward higher-acuity, higher-margin procedures that can be performed in an outpatient setting.
Conifer handles revenue cycle work, which means billing, collections, and payment administration. Tenet returned to full ownership of Conifer effective January 1, 2026. Management emphasizes that AI and automation are materially improving productivity there and across hospital administration.
Care sites and payment pipes
USPI ambulatory surgery centers
USPI operates 520 ambulatory surgery centers. These centers focus on outpatient procedures, including orthopedics, gastroenterology, and urology.
USPI surgical hospitals
Tenet also owns 24 surgical hospitals through USPI. These facilities support higher-acuity procedures that can still be done outside a traditional hospital setting.
Acute care hospitals
Tenet operates 49 hospitals that provide inpatient care, emergency care, surgeries, and specialty services. This is the biggest revenue base, but it is more exposed to labor costs and reimbursement policy.
Physicians and outpatient support sites
The hospital segment includes employed physicians, imaging centers, urgent care, and other outpatient locations. These sites help feed patient volume into Tenet's broader care network.
Conifer revenue cycle services
Conifer helps manage billing and collections. Full ownership gives Tenet more control, and AI-driven automation may improve productivity, but the total savings are not yet fully quantified.
Mix still leans hospital
Segment mix uses first quarter 2026 net operating revenue. Hospital Operations and Services was $4.048 billion, while Ambulatory Care was $1.320 billion. Hospitals are still most of the revenue base, while USPI is the faster-growing piece.
What could break the plan
OBBBA Medicaid shock
High impact · Medium oddsTenet says OBBBA is expected to materially affect Medicaid funding and enrollment, with major healthcare provisions starting in 2027. If more patients lose coverage or Medicaid payments fall, hospitals could see lower revenue and more unpaid care. The risk is large because Tenet has not yet put a dollar range on it.
Hospital margin pressure
High impact · Medium oddsThe hospital segment is still the largest revenue source. It can be hurt by nurse shortages, wage inflation, weak payer mix, and exchange enrollment declines. Exchange revenues fell 17 percent in the second quarter of 2026, meaning Tenet must rely heavily on cost controls to protect margins.
USPI acquisition discipline
Medium impact · Medium oddsTenet is using acquisitions to grow ambulatory surgery centers, aiming for over $300 million in deals for 2026. That works well if prices are fair and new centers ramp as planned. It hurts returns if Tenet overpays for ASCs or buys centers with weaker procedure volume.
Capital allocation misstep
Medium impact · Medium oddsTenet has massive cash resources, including a new $2 billion share repurchase authorization and $1.9 billion incoming from the Conifer deal. Returns could suffer if cash goes to expensive hospital investments or if buybacks are executed at a poor price.
AI and automation risk
Medium impact · Low oddsManagement says AI and automation are improving productivity, especially in Conifer and administrative work. Tenet also names AI as a risk factor, which means errors, privacy issues, bad outputs, or system failures could create legal and operating problems. The upside is real, but execution risks remain.
In one breath
What does Tenet Healthcare do?
Tenet runs hospitals and outpatient surgery centers. Its USPI business operates ambulatory surgery centers, while its hospital segment provides emergency care, inpatient care, outpatient care, and surgeries.
Why is USPI important to Tenet?
USPI is Tenet's faster-growing ambulatory care business. It generates high margins by focusing on complex procedures like joint replacements in an outpatient setting.
What is the biggest risk for Tenet stock?
The biggest long-term risk is OBBBA, because Tenet says it is expected to materially affect Medicaid funding and enrollment starting in 2027. The company has not yet given a clear dollar estimate of the impact.
Is Tenet returning cash to shareholders?
Yes. In July 2026, the board authorized a $2 billion increase to the share repurchase program, adding to a history of aggressive buybacks.
